{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:26:05Z","timestamp":1779287165794,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011482","name":"Yantai Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011482","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.steroids.2020.108585","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T11:18:32Z","timestamp":1579778312000},"page":"108585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["1,25-Dihydroxy vitamin D3 inhibits the Ras-MEK-ERK pathway and regulates proliferation and apoptosis of papillary thyroid carcinoma"],"prefix":"10.1016","volume":"159","author":[{"given":"Baoyuan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weilong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.steroids.2020.108585_b0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40659-017-0140-9","article-title":"Awareness and current knowledge of breast cancer","volume":"50","author":"Akram","year":"2017","journal-title":"Biol. Res."},{"issue":"1","key":"10.1016\/j.steroids.2020.108585_b0010","first-page":"9","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.steroids.2020.108585_b0015","first-page":"52","article-title":"Breast cancer statistics, 2013","volume":"64","author":"Desantis","year":"2014","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.steroids.2020.108585_b0020","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.steroids.2020.108585_b0025","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1210\/er.2018-00126","article-title":"Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions","volume":"40","author":"Bouillon","year":"2019","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.steroids.2020.108585_b0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.prp.2015.11.019","article-title":"HER-2, ER, PR status concordance in primary breast cancer and corresponding metastatic lesion in lymph node in Chinese women","volume":"212","author":"Mh","year":"2016","journal-title":"Pathol. Res. Pract."},{"issue":"4","key":"10.1016\/j.steroids.2020.108585_b0035","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12609-018-0290-y","article-title":"Adjuvant HER2-targeted therapy update in breast cancer: escalation and de-escalation of therapy in 2018","volume":"10","author":"Murthy","year":"2018","journal-title":"Curr. Breast Cancer Rep."},{"issue":"7","key":"10.1016\/j.steroids.2020.108585_b0040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/cells7070076","article-title":"Current status of fibroblast growth factor receptor-targeted therapies in breast cancer","volume":"7","author":"Sobhani","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.steroids.2020.108585_b0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fonc.2018.00089","article-title":"Current therapies for human epidermal growth factor receptor 2-positive metastatic breast cancer patients","volume":"8","author":"Larionov","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.steroids.2020.108585_b0050","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.2147\/OTT.S126051","article-title":"Targeting the androgen receptor in triple-negative breast cancer: current perspectives","volume":"10","author":"Mina","year":"2017","journal-title":"Onco Targets Ther."},{"issue":"6","key":"10.1016\/j.steroids.2020.108585_b0055","first-page":"2659","article-title":"Effects of 1,25(OH)2D3 on proliferation and apoptosis of human glomerular mesangial cells","volume":"8","author":"Zhang","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"2","key":"10.1016\/j.steroids.2020.108585_b0060","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.steroids.2020.108585_b0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2741\/e765","article-title":"EGFR and HER2 signaling in breast cancer brain metastasis","volume":"8","author":"Sirkisoon","year":"2016","journal-title":"Front. Biosci."},{"issue":"1","key":"10.1016\/j.steroids.2020.108585_b0070","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.steroids.2020.108585_b0075","first-page":"1","article-title":"Tamoxifen action in ER-negative breast cancer","volume":"5","author":"Manna","year":"2016","journal-title":"Sign. Transduct. Insights"},{"issue":"9","key":"10.1016\/j.steroids.2020.108585_b0080","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/cncr.29936","article-title":"Annual report to the nation on the status of cancer, 1975\u20132012, featuring the increasing incidence of liver cancer","volume":"122","author":"Ryerson","year":"2016","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.steroids.2020.108585_b0085","first-page":"388","article-title":"Incidence and mortality of liver cancer in China, 2010","volume":"33","author":"Wei","year":"2014","journal-title":"Chin. J. Cancer"},{"issue":"1","key":"10.1016\/j.steroids.2020.108585_b0090","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1016\/j.jhep.2015.02.007","article-title":"Liver cancer: approaching a personalized care","volume":"62","author":"Bruix","year":"2015","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.steroids.2020.108585_b0095","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/10286020.2017.1343303","article-title":"Two new prenylflavonoids from Morus alba","volume":"20","author":"Gao","year":"2018","journal-title":"J. Asian Nat. Prod. Res."},{"issue":"2","key":"10.1016\/j.steroids.2020.108585_b0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bmcl.2016.11.046","article-title":"Bioactive chemical constituents from the root bark of Morusaustralis","volume":"27","author":"Liao","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.steroids.2020.108585_b0105","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejmech.2016.01.012","article-title":"PI3K\/Akt\/mTOR and Ras\/Raf\/MEK\/ERK signaling pathways inhibitors as anticancer agents: structural and pharmacological perspectives","volume":"109","author":"Asati","year":"2016","journal-title":"Euro J. Med. Chem."},{"issue":"6","key":"10.1016\/j.steroids.2020.108585_b0110","first-page":"3485","article-title":"Daidzein exerts anticancer activity towards SKOV3 human ovarian cancer cells by inducing apoptosis and cell cycle arrest, and inhibiting the Raf\/MEK\/ERK cascade","volume":"41","author":"Hua","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.steroids.2020.108585_b0115","doi-asserted-by":"crossref","first-page":"11255","DOI":"10.1038\/s41598-018-29308-7","article-title":"Flavonoids inhibit cell proliferation and induce apoptosis and autophagy through downregulation of PI3K mediated PI3K\/AKT\/mTOR\/p70S6K\/ULK signaling pathway in human breast cancer cells","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.steroids.2020.108585_b0120","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/carcin\/bgy038","article-title":"Sorafenib inhibits proliferation and invasion in desmoid-derived cells by targeting Ras\/MEK\/ERK and PI3K\/Akt\/mTOR pathways","volume":"10","author":"Rosenberg","year":"2018","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.steroids.2020.108585_b0125","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s13765-016-0160-0","article-title":"The natural flavone eupatorin induces cell cycle arrest at the G2\/M phase and apoptosis in HeLa cells","volume":"59","author":"Lee","year":"2016","journal-title":"Appl. Biol. Chem."},{"key":"10.1016\/j.steroids.2020.108585_b0130","first-page":"5","article-title":"World cancer report 2014","volume":"1","author":"Stewart","year":"2017","journal-title":"Health"},{"key":"10.1016\/j.steroids.2020.108585_b0135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.biopha.2015.08.005","article-title":"MicroRNA-143 enhances chemosensitivity of Quercetin through autophagy inhibition via target GABARAPL1 in gastric cancer cells","volume":"74","author":"Du","year":"2015","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.steroids.2020.108585_b0140","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.3892\/or.2015.3915","article-title":"Silibinin, a natural flavonoid, induces autophagy via ROS-dependent mitochondrial dysfunction and loss of ATP involving BNIP3 in human MCF7 breast cancer cells","volume":"33","author":"Jiang","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.steroids.2020.108585_b0145","doi-asserted-by":"crossref","first-page":"30496","DOI":"10.1038\/srep30496","article-title":"Galangin induces autophagy via deacetylation of LC3 by SIRT1 in HepG2 cells","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.steroids.2020.108585_b0150","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1136\/gutjnl-2014-307900","article-title":"New Wnt\/\u03b2-catenin target genes promote experimental metastasis and migration of colorectal cancer cells through different signals","volume":"65","author":"Qi","year":"2016","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.steroids.2020.108585_b0155","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.bbamcr.2018.10.005","article-title":"Mutant p53 prevents GAPDH nuclear translocation in pancreatic cancer cells favoring glycolysis and 2-deoxyglucose sensitivity","volume":"1865","author":"Butera","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell. Res."},{"issue":"10","key":"10.1016\/j.steroids.2020.108585_h0160","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3390\/molecules22101551","article-title":"Current development status of MEK inhibitors","volume":"22","author":"Cheng","year":"2017","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.steroids.2020.108585_h0165","first-page":"19","article-title":"Molecular interplay between mutant p53 proteins and autophagy in cancer cells","volume":"1867","author":"Cordani","year":"2017","journal-title":"BBA-Rev. Cancer"},{"issue":"1","key":"10.1016\/j.steroids.2020.108585_b0165","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12032-016-0862-5","article-title":"K-Ras, H-Ras, N-Ras and B-Raf mutation and expression analysis in Wilms tumors: association with tumor growth","volume":"34","author":"Dalpa","year":"2017","journal-title":"Med. Oncol."},{"issue":"11","key":"10.1016\/j.steroids.2020.108585_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10110403","article-title":"Simultaneous inhibition of MEK and Hh signaling reduces pancreatic cancer metastasis","volume":"10","author":"Gu","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.steroids.2020.108585_b0175","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mod.2018.05.007","article-title":"Regulation and function of p53: a perspective from, Drosophila, studies","volume":"154","author":"Ingaramo","year":"2018","journal-title":"Mech. Dev."},{"key":"10.1016\/j.steroids.2020.108585_b0180","first-page":"73","article-title":"Pancreatic cancer. Lancet North","volume":"388","author":"Kamisawa","year":"2016","journal-title":"Am. Ed."},{"key":"10.1016\/j.steroids.2020.108585_b0185","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2018.09.013","article-title":"KRAS targeting antibody synergizes anti-cancer activity of gemcitabine against pancreatic cancer","volume":"438","author":"Kang","year":"2018","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.steroids.2020.108585_b0190","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/cdd.2017.185","article-title":"Mutant p53 partners in crime","volume":"25","author":"Kim","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.steroids.2020.108585_b0195","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.1038\/sj.onc.1203015","article-title":"Regulation of p53 in response to DNA damage","volume":"18","author":"Lakin","year":"1999","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.steroids.2020.108585_b0200","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/mc.22830","article-title":"A novel tricarbonylmethane agent (CMC2.24) reduces human pancreatic tumor growth in mice by targeting Ras","volume":"57","author":"Mallangada","year":"2018","journal-title":"Mol. Carcinog."},{"issue":"581\u2013591","key":"10.1016\/j.steroids.2020.108585_b0205","article-title":"Fluctuations in p53 signaling allow escape from cell-cycle arrest","volume":"71","author":"Reyes","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.steroids.2020.108585_b0210","first-page":"7","article-title":"Cancer statistics","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.steroids.2020.108585_b0215","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.biopha.2018.03.071","article-title":"Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and\/or inhibiting NF-kappa B signaling or PI3K\/AKT\/mTOR pathway","volume":"102","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X20300106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X20300106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:04:57Z","timestamp":1758535497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X20300106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":44,"alternative-id":["S0039128X20300106"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2020.108585","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1,25-Dihydroxy vitamin D3 inhibits the Ras-MEK-ERK pathway and regulates proliferation and apoptosis of papillary thyroid carcinoma","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2020.108585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108585"}}